These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 32370197

  • 1. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
    Wu CY, Chan CH, Dubey NK, Wei HJ, Lu JH, Chang CC, Cheng HC, Ou KL, Deng WP.
    Int J Mol Sci; 2020 May 02; 21(9):. PubMed ID: 32370197
    [Abstract] [Full Text] [Related]

  • 2. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.
    Milewski D, Pradhan A, Wang X, Cai Y, Le T, Turpin B, Kalinichenko VV, Kalin TV.
    Oncogene; 2017 Feb 09; 36(6):850-862. PubMed ID: 27425595
    [Abstract] [Full Text] [Related]

  • 3. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK, Lee JS, Sukumar S.
    Cell Signal; 2012 Jan 09; 24(1):316-24. PubMed ID: 21964066
    [Abstract] [Full Text] [Related]

  • 4. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
    Shi Y, Chen J, Li Z, Zhang Z, Yu H, Sun K, Wang X, Song X, Wang Y, Zhen Y, Yang T, Lou K, Zhang Y, Zhang G, Hu Y, Ji J, Hui R.
    Oncogene; 2011 Sep 29; 30(39):4107-17. PubMed ID: 21499297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epigenetic activation of FOXF1 confers cancer stem cell properties to cisplatin‑resistant non‑small cell lung cancer.
    Zhao J, Xue X, Fu W, Dai L, Jiang Z, Zhong S, Deng B, Yin J.
    Int J Oncol; 2020 May 29; 56(5):1083-1092. PubMed ID: 32319573
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, Chen M.
    Tumour Biol; 2015 Mar 29; 36(3):1903-11. PubMed ID: 25432132
    [Abstract] [Full Text] [Related]

  • 10. Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer.
    Fu H, Gao H, Qi X, Zhao L, Wu D, Bai Y, Li H, Liu X, Hu J, Shao S.
    Cancer Commun (Lond); 2018 May 08; 38(1):18. PubMed ID: 29764507
    [Abstract] [Full Text] [Related]

  • 11. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F, Zhao Y, Liu J.
    Int J Biochem Cell Biol; 2020 Jun 08; 123():105750. PubMed ID: 32325280
    [Abstract] [Full Text] [Related]

  • 12. HIST1H3D: A promising therapeutic target for lung cancer.
    Rui Y, Peng WJ, Wang M, Wang Q, Liu ZL, Chen YQ, Huang LN.
    Int J Oncol; 2017 Mar 08; 50(3):815-822. PubMed ID: 28112369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC, Chang TW, Tseng YL, Lee JC, Chang MC.
    Carcinogenesis; 2014 Jul 08; 35(7):1481-90. PubMed ID: 24403312
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
    Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, Ginneberge D, Parthoens E, Vandenbussche J, Gevaert K, van Roy F.
    BMC Cancer; 2015 May 10; 15():391. PubMed ID: 25958384
    [Abstract] [Full Text] [Related]

  • 17. BARX1 repressed FOXF1 expression and activated Wnt/β-catenin signaling pathway to drive lung adenocarcinoma.
    Guan X, Liang J, Xiang Y, Li T, Zhong X.
    Int J Biol Macromol; 2024 Mar 10; 261(Pt 2):129717. PubMed ID: 38290639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.